Jefferies Financial Group Forecasts Strong Price Appreciation for Tyra Biosciences (NASDAQ:TYRA) Stock
Jefferies Financial Group has raised its price target for Tyra Biosciences (NASDAQ:TYRA) stock from $32.00 to $43.00, maintaining a "buy" rating and suggesting a substantial potential upside of 38.62%. This positive outlook aligns with a "Moderate Buy" consensus among analysts, despite a recent insider stock sale by Director Robert J. More. The company, a clinical-stage precision oncology firm, reported earnings per share of ($0.50) for its last quarter and has a market capitalization of $1.66 billion.
https://www.marketbeat.com/instant-alerts/jefferies-financial-group-forecasts-strong-price-appreciation-for-tyra-biosciences-nasdaqtyra-stock-2026-02-03/